Bradley L Campbell - Net Worth and Insider Trading

Bradley L Campbell Net Worth

The estimated net worth of Bradley L Campbell is at least $9 Million dollars as of 2024-04-26. Bradley L Campbell is the President and CEO of Amicus Therapeutics Inc and owns about 886,654 shares of Amicus Therapeutics Inc (FOLD) stock worth over $9 Million. Details can be seen in Bradley L Campbell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bradley L Campbell has not made any transactions after 2024-04-01 and currently still holds the listed stock(s).

Transaction Summary of Bradley L Campbell

To

Bradley L Campbell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bradley L Campbell owns 4 companies in total, including Amicus Therapeutics Inc (FOLD) , ARYA Sciences Acquisition Corp III (ARYA) , and Progenics Pharmaceuticals Inc (PGNX) among others .

Click here to see the complete history of Bradley L Campbell’s form 4 insider trades.

Insider Ownership Summary of Bradley L Campbell

Ticker Comapny Transaction Date Type of Owner
FOLD Amicus Therapeutics Inc 2024-04-01 director & President and CEO
ARYA ARYA Sciences Acquisition Corp III 2020-08-06 director
PGNX Progenics Pharmaceuticals Inc 2020-06-19 director
NAUT Nautilus Biotechnology Inc 2020-08-06 director

Bradley L Campbell Latest Holdings Summary

Bradley L Campbell currently owns a total of 1 stock. Bradley L Campbell owns 886,654 shares of Amicus Therapeutics Inc (FOLD) as of April 1, 2024, with a value of $9 Million.

Latest Holdings of Bradley L Campbell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FOLD Amicus Therapeutics Inc 2024-04-01 886,654 10.17 9,017,271

Holding Weightings of Bradley L Campbell


Bradley L Campbell Form 4 Trading Tracker

According to the SEC Form 4 filings, Bradley L Campbell has made a total of 58 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years, including 0 buys and 58 sells. The most-recent trade in Amicus Therapeutics Inc is the sale of 7,500 shares on April 1, 2024, which brought Bradley L Campbell around $87,525.

Insider Trading History of Bradley L Campbell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bradley L Campbell Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bradley L Campbell Ownership Network

Ownership Network List of Bradley L Campbell

No Data

Ownership Network Relation of Bradley L Campbell


Bradley L Campbell Owned Company Details

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Bradley L Campbell is the director & President and CEO of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & Executive Chairman John F Crowley , Chief People Officer David Michael Clark , and General Counsel & Corp. Secy Ellen Rosenberg .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Bradley L Campbell made 21 insider transaction in Amicus Therapeutics Inc (FOLD) with a net sale of 258,416. Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 645,546 shares made by John F Crowley , a net sale of 51,919 shares made by David Michael Clark , and a net sale of 126,839 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 185,169 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 185,169 shares. During the past 18 months, 1,242,298 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,242,298 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amicus Therapeutics Inc Insider Transactions

No Available Data

Bradley L Campbell Mailing Address

Above is the net worth, insider trading, and ownership report for Bradley L Campbell. You might contact Bradley L Campbell via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.

Discussions on Bradley L Campbell

No discussions yet.